Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients

Previous studies have shown that hepatitis B core antibody (anti-HBc) levels vary during different phases of disease in treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predictor of both interferon-α and nucleoside analogue therapy response. However, there is no information on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min-Ran, Lu, Jian-Hua, Ye, Li-Hong, Sun, Xing-Li, Zheng, Yan-Hua, Liu, Zhi-Quan, Zhang, Hai-Cong, Liu, Yun-Yan, Lv, Ying, Huang, Yan, Dai, Er-Hei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400315/
https://www.ncbi.nlm.nih.gov/pubmed/27559949
http://dx.doi.org/10.1097/MD.0000000000004422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400315/
https://www.ncbi.nlm.nih.gov/pubmed/27559949
http://dx.doi.org/10.1097/MD.0000000000004422

Ejemplares similares